跳至主要内容
临床试验/NCT03328871
NCT03328871Unknown3 期

The Combination Therapy of Fractional Laser and Platelet-Rich Plasma Injection Compared With Nanofat Grafting and Platelet-Rich Plasma Synergy in Treating Striae Gravidarum.

First Affiliated Hospital of Jinan University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
10
试验地点
1
主要终点
Immunohistochemical analysis

研究概览

简要总结

Nowadays, multiple treatment modalities have been applied clinically to treat striae gravidarum, such as laser therapy, microdermabrasion, platelet-rich plasma injection(PRP), etc. To some extent, these treatments can improve striae gravidarum. In this clinical trial, the investigators are going to treat striae gravidarum by using two different kinds of combination therapies. One is fractional laser and PRP injection synergy, and the other one is treated by nanofat grafting with PRP injection.

详细描述

The investigators will pick out two areas of most severe striae gravidarum on a participant's abdomen. One of the areas will be treated by fractional laser once every three months for 2 times combined with PRP injection once a month for 6 times. Another area will be treated by nanofat grafting once every three months for 2 times and PRP therapy once a month for 6 times. The participants were asked to come back 1、3、6、9 months after treatment for further follow-up.

Before and after the treatment, the striae gravidarum will be assessed subjectively by satisfaction assessment, dermatoscope and ultrasound, and objectively by immunohistochemical analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 35 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • The striae gravidarum was appeared within 3 years
  • Age ≤ 35 years old
  • Not in lactation
  • Not pregnancy within one year

排除标准

  • Skin allergy
  • Skin inflammation or wound
  • Platelet dysfunction syndrome
  • Take anticoagulant drugs
  • Acute or chronic infection
  • Chronic liver disease
  • Photodermatosis
  • Active vitiligo, psoriasis, systemic lupus erythematosus
  • Other clinical trial

结局指标

主要结局

Immunohistochemical analysis

时间窗: Baseline and 15 months.

The tissue extracted will be taken for immunohistochemical analysis to observe the change of epidermal and dermal thickness, and the distribution and amount of elastic fiber and collagen fiber,etc.

次要结局

  • Ultrasound(Baseline and at 3,6,9,12,15 months after the treatments.)
  • Dermatoscope(Baseline and at 3,6,9,12,15 months after the treatments.)

研究者

发起方
First Affiliated Hospital of Jinan University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Li-Ling Xiao

Associate Chief of Department of Plastic Surgery,The First Affiliated Hospital of Jinan University, Guangzhou

First Affiliated Hospital of Jinan University

研究点 (1)

Loading locations...

相似试验